AMENDED & RESTATED CREDIT FACILITY AGREEMENTCredit Facility Agreement • March 16th, 2018 • Fortress Biotech, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 16th, 2018 Company Industry JurisdictionThis AMENDED AND RESTATED CREDIT FACILITY AGREEMENT (this “Agreement”), dated as of March 12, 2018 (the “A&R Agreement Date”), is made by and among FORTRESS BIOTECH, INC., a Delaware corporation (the “Borrower”), and each of OPUS POINT HEALTHCARE INNOVATIONS FUND, LP (“Opus”) and any other lenders listed on the signature pages hereto (Opus and any other lenders, together with their successors and permitted assigns, the “Lenders” and, together with the Borrower, the “Parties”).
CREDIT FACILITY AGREEMENTCredit Facility Agreement • November 9th, 2016 • Fortress Biotech, Inc. • Pharmaceutical preparations • New York
Contract Type FiledNovember 9th, 2016 Company Industry JurisdictionCREDIT FACILITY AGREEMENT (this “Agreement”), dated as of September 14, 2016, is made by and among FORTRESS BIOTECH, INC., a Delaware corporation (the “Borrower”), and each of OPUS POINT HEALTHCARE INNOVATIONS FUND, LP (“Opus”) and any other lenders listed on the signature pages hereto (Opus and any other lenders, together with their successors and permitted assigns, the “Lenders” and, together with the Borrower, the “Parties”).